Preclinical evaluation of a natural extract-based oral nanoformulation from Eucalyptus tereticornis for potential use in treating type 2 diabetes mellitus.
Natalia Arbeláez, Elkin Escobar-Chaves, Andrea Correa, Adriana Restrepo, Sergio Acı́n, Jahir Orozco, Norman Balcázar
This paper evaluates the safety of a nanoformulation from Eucalyptus tereticornis in preclinical models, finding no toxic effects across multiple toxicity studies.
bioRxiv · Apr 20, 2026 · PreprintPharmacology & Toxicology